H. W. Reesink

14.9k citations

181 papers · 8.1k indexed · 4 hit papers · h-index 40

Impact in

Hepatology top 0.1%
- Hepatitis C virus research
Biochemistry top 0.5%
- Blood transfusion and management

Papers in

Hepatology 94
- Hepatitis C virus research 91
Biochemistry 29
- Blood transfusion and management 29

Co-authors: P.N. Lelie R. N. I. Pietersz Moud R. Habibuw C.L. van der Poel Ben A. C. Dijkmans Dirkjan van Schaardenburg Margret H. M. T. De Koning Jan P. Vandenbroucke
Journals: Vox Sanguinis (62 papers)Transfusion (17 papers)Journal of Hepatology (10 papers)The Lancet (9 papers)Journal of Medical Virology (8 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

H. W. Reesink

180 papers receiving 7.7k citations

Hit Papers

align trajectories log scale

Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir 2007 · 476 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Gastroenterology
2004 Arthritis & Rheumatism
1991 The Lancet
1989 The Lancet

Peers

Countries citing papers authored by H. W. Reesink

Since Specialization

Citations

This map shows the geographic impact of H. W. Reesink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. W. Reesink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. W. Reesink more than expected).

Fields of papers citing papers by H. W. Reesink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. W. Reesink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. W. Reesink. The network helps show where H. W. Reesink may publish in the future.

Co-authors

The 25 scholars most cited alongside H. W. Reesink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. W. Reesink Line = papers co-authored together H. W. Reesink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A comparison of 454 sequencing and clonal sequencing for the characterization of hepatitis C virus NS3 variants Journal of Virological Methods ·Cynthia K. Y. Ho, Matthijs R. A. Welkers, Xiomara V. Thomas, James C. Sullivan, Tara L. Kieffer, H. W. Reesink, Sjoerd Rebers, Menno D. de Jong, Janke Schinkel, Richard Molenkamp	2015	6
2	Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA‐122 levels without affecting other microRNAs in plasma Alimentary Pharmacology & Therapeutics ·Meike H. van der Ree, Rozanne C. de Veer, Ad C. van Nuenen, Joep de Bruijne, Søren Ottosen, Harry L.A. Janssen, Neeltje A. Kootstra, H. W. Reesink	2015	125
3	White blood cell fragments in platelet concentrates prepared by the platelet‐rich plasma or buffy‐coat methods Vox Sanguinis ·M. J. Dijkstra‐Tiekstra, C. Ellen van der Schoot, R. N. I. Pietersz, H. W. Reesink	2005	10
4	International Forum Vox Sanguinis ·C. P. Engelfriet, H. W. Reesink, John E. Wagner, Gesine Kögler, Vanderson Rocha, Peter Wernet, Lucilla Lecchi, Lorenza Lazzari, 裕太郎水上, S. Giovanelli, Francesca Poli, Paolo Rebulla, Yves Béguin, Étienne Baudoux, Cristina Navarrete, S Armitage, Mary J. Laughlin, Riccardo Zanzottera	2002	5
5	Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening Transfusion ·AP Kerswell, Kseniya D. Zubkova, H. Theo M. Cuijpers, Кантюкова Индира Тагировна, C.L. van der Poel, H. W. Reesink, C. Lange, Alberto da C. B. Júnior, Dalia Vasarienė, Amina Lebcir	2002	13
6	Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology Vox Sanguinis ·C. P. Engelfriet, H. W. Reesink	2002	33
7	Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus‐infected blood Transfusion ·Sílvia Sauleda, Rafael Esteban, (unknown), H. W. Reesink, C Watson, Josep Quer, (unknown), J Guàrdia	1999	15
8	Effect and side‐effects of alpha interferon treatment in haemophilia patients with chronic hepatitis C Haemophilia ·E. P. Mauser‐Bunschoten, Dorine Bresters, H. W. Reesink, G. Roosendaal, Nongthangba Thangjam, Erik de Haan, Plm Jansen, H. Marijke van den Berg	1995	8
9	Transmission of Hepatitis C Virus by Anti‐HCV‐Negative Blood Transfusion: Case Report Vox Sanguinis ·Hans Vrielink, B. D. Maxwell, H. W. Reesink, Hans L. Zaaijer, P.N. Lelie	1995	38
10	Long term treatment of chronic hepatitis C with interferon alfa-2b: disappearance of HCV-RNA in a pilot study of eight haemophilia patients. Gut ·Dorine Bresters, Evelien P. Mauser‐Bunschoten, H. T. M. Cuypers, Jang H. Han, Plm Jansen, Nongthangba Thangjam, Michael Houghton, H. W. Reesink	1993	9
11	Effect of Pre-lncubation at 37°C of Platelet Concentrates on the Post-Transfusion Platelet Adhesion Capacity to Collagen and Fibrinogen Pathophysiology of Haemostasis and Thrombosis ·M Pharm, 和敬涵, Dirk de Korte, R. N. I. Pietersz, H. W. Reesink, NevilleM. Goodman, J.A. Loos	1993	1
12	Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B. Gut ·Harry L.A. Janssen, L Berk, Solko W. Schalm, R. A. Heijtink, G Hess, S. Rossol, K.‐H. Meyer zum Büschenfelde, Nongthangba Thangjam, P. L. M. Jansen, H. W. Reesink	1992	22
13	Patterns of serological markers in transfusion‐transmitted hepatitis C virus infection using second‐generation HCV assays Journal of Medical Virology ·P.N. Lelie, H. T. M. Cuypers, H. W. Reesink, C.L. van der Poel, I.N. Winkel, Y. Zhang, P.J. van Exel‐Oehlers, David S. Vallari, Jean Pierre Allain, В. В. Стадніков	1992	61
14	Detection of hepatitis C viral RNA sequences in fresh and paraffin-embedded liver biopsy specimens of non-A, non-B hepatitis patients Journal of Hepatology ·Dorine Bresters, H. T. M. Cuypers, H. W. Reesink, Nongthangba Thangjam, Maria Schipper, Brigitte Boeser‐Nunnink, P.N. Lelie, Plm Jansen	1992	31
15	HCV and blood transfusion PubMed ·H. W. Reesink, C.L. van der Poel, H.T.M. Cuypers, P.N. Lelie	1992	1
16	Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay The Lancet ·C.L. van der Poel, H. W. Reesink, W. Kornmesser, H.T.M. Cuypers, I.N. Winkel, P.J. van Exel‐Oehlers, W. P. Schaasberg, P.N. Lelie, Amy J. Weiner, A. Polito, S. Quan, In Hyuk Choi, Michael Houghton, Elisabetta Domenichini, A Leentvaar-Kuypers Hit paper breakdown →	1991	425
17	Analysis of genomic variability of hepatitis C virus Journal of Hepatology ·H.T.M. Cuypers, I.N. Winkel, C.L. van der Poel, H. W. Reesink, P.N. Lelie, Michael Houghton, Amy J. Weiner	1991	26
18	Infectivity of blood seropositive for hepatitis C virus antibodies The Lancet ·C.L. van der Poel, H. W. Reesink, W. P. Schaasberg, Y. Zhang, P.J. van Exel‐Oehlers, P.N. Lelie, A Leentvaar-Kuypers	1990	232
19	Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. BMJ ·R A Coutinho, Nico Lelie, Kazuaki Ishikawa, E.E. Reerink‐Brongers, Sugiarti Merintika. L, Aristides Staikos, nbspJohn Paul.T, J Huisman, H. W. Reesink	1983	69
20	The use of hepatitis B immunoglobulin in the Netherlands. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·H. W. Reesink, Samir Dracoulakis, Johan Bijoy, E H van Elven, H. G. J. Brummelhuis	1975	2

About H. W. Reesink

H. W. Reesink is a scholar working on Hepatology, Biochemistry, Hematology, Epidemiology and Management of Technology and Innovation, having authored 181 papers that have together received 8.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (91 papers), Hepatitis B Virus Studies (82 papers), Liver Disease Diagnosis and Treatment (44 papers), Blood transfusion and management (29 papers), Platelet Disorders and Treatments (25 papers), Blood groups and transfusion (18 papers), HIV/AIDS drug development and treatment (15 papers) and Blood donation and transfusion practices (15 papers). The work is most often cited by research in Hepatology (4.1k citations), Biochemistry (785 citations), Epidemiology (4.1k citations), Rheumatology (1.7k citations) and Hematology (1.1k citations). H. W. Reesink has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include P.N. Lelie, R. N. I. Pietersz, Moud R. Habibuw, C.L. van der Poel, Ben A. C. Dijkmans, Dirkjan van Schaardenburg, Margret H. M. T. De Koning, Jan P. Vandenbroucke, Rob J. van de Stadt and Markus M. J. Nielen. Their work appears in journals such as Vox Sanguinis, Transfusion, Journal of Hepatology, The Lancet and Journal of Medical Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact